Speakers

Εvgenia Ioannidi
Biologist, PhD, Biotechnology Operations Director, Demo SA
Giota Kotsekidou
Corporate & Regulatory Affairs Director, AstraZeneca Greece
Ioannis Kotsiopoulos
PIF General Manager
Marios-Athanasios Loupas
Consultant HTA, IQVIA Greece
Christos Martakos
Founding Member & President of the BoD of the scientific association "Market Access Hellenic Society" (MAHS) & Governmental & Industrial Relations Director, Pharmaserve-Lilly S.A.C.I.
Paraskevi Michalopoulou
President of Hellenic Association of  Women with Breast Cancer  “Alma Zois” Vice President of  Hellenic Cancer Federation (ELLOK)
Flora Bakopoulou
Head, Health Technology Assessment (HTA) Committee, Greek Ministry of Health, Professor of Pediatrics-Adolescent Medicine-Clinical Pharmacology, Medical School, National and Kapodistrian University of Athens
Aristotle Bamias MD PhD 
Professor of Internal Medicine-Oncology, National & Kapodistrian University of Athens, Vice Chair, Hellenic Society of Medical Oncology (heSMO) Chair, Hellenic GU Cancer Group (HGUCG)
Dimitrios Boucharas
Software Engineer and Ph.D. candidate in Mathematics and Computer Science, University of Ioannina
Vicky Oikonomou
Governmental and Strategic Affairs & Patient Engagement and Advocacy Director, Interim Market Access Director, Johnson & Johnson Innovative Medicine